Home
/

Allergic Rhinitis

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Blood testing for allergic rhinitis uses eosinophils and CRP to distinguish allergy-driven Th2 inflammation from infection-related systemic inflammation. Elevated eosinophils (typically 1–3% of white cells) are associated with itchy, sneezy flares and may help support identification of coexisting asthma, while very low CRP suggests isolated allergy rather than infection. Pairing these markers connects nasal symptoms to broader atopic and systemic inflammation patterns.

Read more →
Table of contents

Allergic Rhinitis and the Immune Signals Behind It

Blood biomarkers for allergic rhinitis capture the immune signature of allergy in circulation, turning sneezing and congestion into measurable signals. The core marker is the allergen‑specific “allergy antibody” that flags your triggers (specific IgE), often paired with a read on overall allergic tendency (total IgE). Counts of allergy‑prone white blood cells (eosinophils) and the proteins they release (eosinophil cationic protein) reflect the intensity of eosinophilic inflammation that drives nasal swelling and itch. Markers of rapid immune activation, which spark symptoms within minutes (mast‑cell mediators such as tryptase), indicate how strongly tissues react when exposed to pollen, dust mites, or pet dander. Upstream signaling molecules that steer the response toward allergy (type 2 cytokines like IL‑4, IL‑5, IL‑13) help map the pathway that sustains symptoms. Together, these tests confirm that symptoms are truly allergy‑driven, pinpoint specific triggers, gauge inflammatory burden, and guide precision treatment—from trigger avoidance and allergen immunotherapy to targeted medicines that block IgE or type 2 signaling.

Why Eosinophils and CRP Help Map Allergy

Allergic rhinitis blood markers show how your immune system is reacting at the airway lining and across the body. They help distinguish a local, allergy‑driven response from broader inflammation that can affect the sinuses, lungs, sleep, and daytime focus.Eosinophils are allergy‑linked white blood cells; a typical proportion is about 1–3% of circulating white cells, and symptom‑control tends to be best when they sit near the low end. C‑reactive protein (CRP), a general inflammation signal, is usually very low in isolated allergic rhinitis; values under the low single digits are common, and the “healthiest” range tends to be at the low end. When eosinophils climb, people are more likely to have itchy, sneezy, watery‑nose flares, swollen turbinates, and, in some, wheeze or cough from coexisting asthma. Marked CRP elevation points away from pure allergy toward infection or systemic inflammation. Children may show higher eosinophils during flares; pregnancy can bring nasal congestion even with normal eosinophils, and CRP can run slightly higher due to normal pregnancy changes.When eosinophils and CRP are both low, it usually means minimal Th2‑type allergic inflammation and little systemic “spillover.” Symptoms, if present, may reflect nonallergic triggers (irritants, temperature shifts) rather than classic IgE‑mediated allergy. Teens and adults can have intermittent allergies with normal eosinophils between flares.Big picture: these markers connect nose symptoms to immune pathways that also touch the lungs (asthma), skin (eczema), eyes (conjunctivitis), and sleep quality. Persistently high eosinophils raise the likelihood of comorbid asthma and chronic sinusitis, while elevated CRP flags broader inflammatory risk relevant to infection and cardiometabolic health. Testing helps map where the inflammation lives and how widespread it is.

What a Blood Panel Adds to Hay-Fever Diagnosis

Allergic rhinitis, often called hay fever, is an immune system response that affects the nose and airways, but its impact can ripple through the whole body. When the immune system is overactive, as in allergic rhinitis, it can influence energy levels, sleep quality, cognitive function, and even cardiovascular health. At Superpower, we test two key blood biomarkers—eosinophils and C-reactive protein (CRP)—to help reveal how your immune system is behaving and whether inflammation is present.Eosinophils are a type of white blood cell that play a central role in allergic reactions. When you have allergic rhinitis, your body may produce more eosinophils as part of its response to allergens. CRP is a protein made by the liver that rises in the blood when there is inflammation anywhere in the body. While CRP is not specific to allergies, it helps indicate whether there is a broader inflammatory process occurring alongside allergic symptoms.Stable, healthy levels of eosinophils suggest that your immune system is balanced and not overreacting to harmless substances. When eosinophils are elevated, it points to ongoing allergic activity, which can disrupt the normal function of the respiratory system and affect overall well-being. A normal CRP level supports the idea that inflammation is limited to the airways, while a higher CRP may signal more widespread inflammation, which can have broader effects on health.Interpretation of these biomarkers can be influenced by factors such as recent infections, age, pregnancy, certain medications, and laboratory methods. These variables can cause temporary changes in eosinophil or CRP levels, so results are best understood in the context of your overall health and history.

FAQs

It checks your bloodstream for signs of allergy-driven inflammation. Superpower measures eosinophils (allergy-associated white blood cells) and CRP (C‑reactive protein, a marker of systemic inflammation). These biomarkers don’t diagnose hay fever by themselves, but they help distinguish an allergic flare from infection and show how active your inflammatory pathways are.

It quantifies the biology behind your symptoms. Higher eosinophils support an allergic pattern (type 2 inflammation), while CRP helps flag non-allergic, systemic inflammation or infection. Together they help explain symptom spikes, guide timing of care, and track response to therapies over time.

Yes. With Superpower, our team member can organize a professional blood draw in your home and handle the logistics end to end.

Get a baseline when you’re stable. Recheck during your peak allergy season or when symptoms change. Many people test 1–2 times per year, and again after major treatment changes, to track trends rather than a single snapshot.

Allergen exposure can raise eosinophils; asthma or eczema do too. Systemic steroids or biologics lower eosinophils. Infections, recent vaccination, smoking, obesity, and acute stress can raise CRP. Eosinophils vary by time of day (lower in the morning). Heavy exercise and intercurrent illness can transiently shift results.

No fasting is required. Stay well hydrated. A morning draw improves consistency for eosinophils. Avoid unusually strenuous exercise the day before. Continue regular medicines unless told otherwise, but note if you’re on steroids or biologics. If you have a new fever, consider timing the test to reflect your usual baseline.

References

  1. Min, Y.-G. (2010). The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy, Asthma & Immunology Research, 2(2), 65-76. https://doi.org/10.4168/aair.2010.2.2.65
  2. Corsico, A. G., De Amici, M., Ronzoni, V., Giunta, V., Mennitti, M. C., Viscardi, A., Marseglia, G. L., & Ciprandi, G. (2017). Allergen-specific immunoglobulin E and allergic rhinitis severity. Allergy & Rhinology, 8(1), e1-e4. https://doi.org/10.2500/ar.2017.8.0187
  3. Benson, V. S., Hartl, S., Barnes, N., Galwey, N., Van Dyke, M. K., & Kwon, N. (2022). Blood eosinophil counts in the general population and airways disease: A comprehensive review and meta-analysis. European Respiratory Journal, 59(1), 2004590. https://doi.org/10.1183/13993003.04590-2020
  4. Singh, B., Goyal, A., & Patel, B. C. (2025). C-reactive protein: Clinical relevance and interpretation. In StatPearls. StatPearls Publishing. https://pubmed.ncbi.nlm.nih.gov/28722873/
  5. Brozek, J. L., Bousquet, J., Baena-Cagnani, C. E., Bonini, S., Canonica, G. W., Casale, T. B., van Wijk, R. G., Ohta, K., Zuberbier, T., & Schunemann, H. J. (2010). Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. Journal of Allergy and Clinical Immunology, 126(3), 466-476. https://doi.org/10.1016/j.jaci.2010.06.047

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey